A detailed history of Monashee Investment Management LLC transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Monashee Investment Management LLC holds 147,049 shares of RGLS stock, worth $241,160. This represents 0.03% of its overall portfolio holdings.

Number of Shares
147,049
Previous 197,049 25.37%
Holding current value
$241,160
Previous $352,000 34.66%
% of portfolio
0.03%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.46 - $1.9 $73,000 - $95,000
-50,000 Reduced 25.37%
147,049 $230,000
Q2 2024

Aug 12, 2024

SELL
$1.79 - $2.8 $766,032 - $1.2 Million
-427,951 Reduced 68.47%
197,049 $352,000
Q1 2024

May 14, 2024

BUY
$1.13 - $2.88 $706,249 - $1.8 Million
625,000 New
625,000 $1.8 Million

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $24M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.